Institutional Capital’s Bristol-Myers Squibb BMY Stock Holding History

Institutional Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,063,078	Closed	-$358M	–	46
2014 Q4	$358M	Sell	6,063,078 -4,446,433	-42%	-$251M	2.15%	23
2014 Q3	$538M	Sell	10,509,511 -2,122,584	-17%	-$106M	3.14%	13
2014 Q2	$613M	Buy	12,632,095 +10,022,466	+384%	+$494M	2.91%	20
2014 Q1	$136M	Buy	+2,609,629	New	+$139M	0.64%	36

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Institutional Capital's BMY Position: Q1 2015 in Review

Institutional Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2015, closing a stake of 6,063,078 shares — an estimated $358M sold.

Institutional Capital first reported a position in BMY in Q1 2014 and held it in 4 quarters. The position peaked at $613M in Q2 2014. 1,448 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

Institutional Capital reported no remaining Bristol-Myers Squibb position as of Q1 2015 after selling out during the quarter.
Institutional Capital sold 6,063,078 Bristol-Myers Squibb shares in Q1 2015, an estimated $358M.
Institutional Capital first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 4 quarters.
Institutional Capital's Bristol-Myers Squibb position peaked at $613M in Q2 2014.
1,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Institutional Capital's 13F filing for Q1 2015, filed 13 May 2015.